These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35457733)

  • 41. Burden of smoking on disease-specific mortality, DALYs, costs: the case of a high-income European country.
    Farcher R; Syleouni ME; Vinci L; Mattli R
    BMC Public Health; 2023 Apr; 23(1):698. PubMed ID: 37060054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thirty-year changes in disability adjusted life years for colorectal cancer in China: a screening perspective analysis].
    Li YJ; Cao MD; Wang X; Lei L; Peng J; Shi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1381-1387. PubMed ID: 36117343
    [No Abstract]   [Full Text] [Related]  

  • 43. Cost and disease burden of dengue in Cambodia.
    Beauté J; Vong S
    BMC Public Health; 2010 Aug; 10():521. PubMed ID: 20807395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic Burden and Disability-Adjusted Life Years (DALYs) of Attention Deficit/Hyperactivity Disorder.
    Hong M; Park B; Lee SM; Bahn GH; Kim MJ; Park S; Oh IH; Park H
    J Atten Disord; 2020 Apr; 24(6):823-829. PubMed ID: 31364445
    [No Abstract]   [Full Text] [Related]  

  • 45. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.
    Fung A; Horton S; Zabih V; Denburg A; Gupta S
    BMJ Glob Health; 2019; 4(5):e001825. PubMed ID: 31749998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach.
    Bagepally BS; Kumar S S; Sasidharan A
    Clinicoecon Outcomes Res; 2024; 16():187-196. PubMed ID: 38560409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain.
    Pérez-Rubio A; Mestre-Ferrandiz J; López-Belmonte JL; Diaz-Aguiló A; Lorenzo-Herrero S; Crespo C
    BMC Infect Dis; 2024 Aug; 24(1):779. PubMed ID: 39103777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program.
    Carlson LC; Slobogean GP; Pollak AN
    Value Health; 2012; 15(6):887-93. PubMed ID: 22999139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [DALYs for breast cancer in China, 2000-2050: trend analysis and prediction based on GBD 2019].
    Yan XX; Li YJ; Cao MD; Wang H; Liu CC; Wang X; Ran JC; Liang L; Lei L; Peng J; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Dec; 42(12):2156-2163. PubMed ID: 34954980
    [No Abstract]   [Full Text] [Related]  

  • 52. National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015.
    Misganaw A; Melaku YA; Tessema GA; Deribew A; Deribe K; Abera SF; Dessalegn M; Lakew Y; Bekele T; Haregu TN; Amare AT; Gedefaw M; Mohammed M; Yirsaw BD; Damtew SA; Achoki T; Blore J; Krohn KJ; Assefa Y; Kifle M; Naghavi M
    Popul Health Metr; 2017 Jul; 15(1):28. PubMed ID: 28732542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa.
    Koltai M; Moyes J; Nyawanda B; Nyiro J; Munywoki PK; Tempia S; Li X; Antillon M; Bilcke J; Flasche S; Beutels P; Nokes DJ; Cohen C; Jit M
    BMC Med; 2023 Mar; 21(1):120. PubMed ID: 37004062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.
    Alemayehu S; Yigezu A; Hailemariam D; Hailu A
    PLoS One; 2020; 15(7):e0235820. PubMed ID: 32716915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-Effectiveness of Price Subsidies on Fortified Packaged Infant Cereals in Reducing Iron Deficiency Anemia in 6-23-Month-Old-Children in Urban India.
    Plessow R; Arora NK; Brunner B; Wieser S
    PLoS One; 2016; 11(4):e0152800. PubMed ID: 27073892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
    Safiri S; Kolahi AA; Naghavi M;
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017.
    Gańczak M; Miazgowski T; Kożybska M; Kotwas A; Korzeń M; Rudnicki B; Nogal T; Andrei CL; Ausloos M; Banach M; Brazinova A; Constantin MM; Dubljanin E; Herteliu C; Hostiuc M; Hostiuc S; Jakovljevic M; Jozwiak JJ; Kissimova-Skarbek K; Król ZJ; Mestrovic T; Miazgowski B; Milevska Kostova N; Naghavi M; Negoi I; Negoi RI; Pana A; Rubino S; Sekerija M; Sierpinski R; Szponar L; Topor-Madry R; Vujcic IS; Widecka J; Widecka K; Wojtyniak B; Zadnik V; Kopec JA
    PLoS One; 2020; 15(3):e0226766. PubMed ID: 32119685
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.